Phase II trial of fulvestrant in the treatment of recurrent ovarian carcinoma

被引：1
|
作者：
Thomas, S. G. [1 ]
Judson, P. L. [1 ]
Carson, L. F. [1 ]
Downs, L. S., Jr. [1 ]
Gliebre, R. G. [1 ]
Geller, M. A. [1 ]
Jonson, A. L. [1 ]
Argenta, P. A. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
来源：
GYNECOLOGIC ONCOLOGY | 2008年 / 111卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2008.07.063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4
引用
收藏
页码：374 / 375
页数：2
相关论文
共 50 条
  • [31] A phase II trial on the combination of bevacizumab and irinotecan in recurrent ovarian cancer.
    Ling, Huichung Tina
    Muggia, Franco
    Speyer, James L.
    Curtin, John Patrick
    Blank, Stephanie V.
    Boyd, Leslie R.
    Pothuri, Bhavana
    Li, Xiaochun
    Goldberg, Judith D.
    Tiersten, Amy
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
    Jackson, C. G.
    Moore, K. N.
    Cantrell, L.
    Erickson, B. K.
    Duska, L. R.
    Richardson, D. L.
    Landrum, L. M.
    Holman, L. L.
    Walker, J. L.
    Mannel, R. S.
    Moxley, K. M.
    Queimado, L.
    Cohoon, A.
    Ding, K.
    Dockery, L. E.
    GYNECOLOGIC ONCOLOGY, 2022, 166 (01) : 44 - 49
  • [33] Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix
    Jenkins, AD
    Ramondetta, LM
    Sun, C
    Johnston, T
    Wolf, JK
    Bodurka, DC
    Brown, J
    Atkinson, EN
    Levenback, C
    GYNECOLOGIC ONCOLOGY, 2005, 97 (03) : 840 - 844
  • [34] A phase II trial of mitomycin, ifosfamide and cisplatin in recurrent carcinoma of the cervix
    Trudeau, M
    Seymour, R
    Stanimir, G
    Souhami, L
    Arthur, L
    Dulude, H
    Gallant, G
    Leyland-Jones, B
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (03) : 207 - 211
  • [35] A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma
    Selle, F.
    Sevin, E.
    Ray-Coquard, I.
    Mari, V.
    Berton-Rigaud, D.
    Favier, L.
    Fabbro, M.
    Lesoin, A.
    Lortholary, A.
    Pujade-Lauraine, E.
    ANNALS OF ONCOLOGY, 2014, 25 (11) : 2191 - 2196
  • [36] PHASE-II TRIAL OF DIAZIQUONE IN ADVANCED OVARIAN-CARCINOMA
    LUND, B
    BRAMWELL, V
    RENARD, J
    HANSEN, HH
    DOMBERNOWSKY, P
    CANCER TREATMENT REPORTS, 1985, 69 (03): : 339 - 340
  • [37] A PHASE II TRIAL OF SUNITINIB IN THE TREATMENT OF RECURRENT GLIOBLASTOMA (GBM)
    Kreisl, Teri N.
    Smith, P.
    Iwamoto, Fabio
    Sul, Joohee
    Butman, John A.
    Fine, Howard A.
    NEURO-ONCOLOGY, 2010, 12 : 71 - 72
  • [38] Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer
    Song, Taejong
    Kim, Min Kyu
    Lee, Yoo-Young
    Choi, Chel Hun
    Kim, Tae-Joong
    Lee, Jeong-Won
    Kim, Byoung-Gie
    Bae, Duk Soo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (03) : 653 - 660
  • [39] Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer
    Taejong Song
    Min Kyu Kim
    Yoo-Young Lee
    Chel Hun Choi
    Tae-Joong Kim
    Jeong-Won Lee
    Byoung-Gie Kim
    Duk Soo Bae
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 653 - 660
  • [40] Phase II trial of fulvestrant in castration resistant prostate cancer
    Chadha, M. K.
    Ashraf, U.
    Payne, V.
    Silliman, C.
    Escott, P.
    Lawrence, D.
    Tian, L.
    Levine, E.
    Trump, D. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345